What Happened?
New York, NY-based Intercept Pharmaceuticals Appointed Stephen Davis as Chief Information Security Officer
About the Company
We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. We are committed to improving patients` lives and addressing the liver community`s most pressing needs. Our corporate headquarters is located in New York, and we have additional offices in San Diego, London and Perugia.
About the Person
Stephen Davis is Chief Information Security Officer at Intercept Pharma. Previously, Stephen Davis was Director - Information Security Operations at Discovery Education. Previously - Stephen Davis held various leadership positions in the industry.
Info Source
News
Short Profile